|
ACN9 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.18719478692242E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.60440549734631E-11 |
| Normal-vs-Stage2 |
1.391550E-02 |
| Normal-vs-Stage3 |
2.3847035457436E-11 |
| Normal-vs-Stage4 |
1.62458935193399E-12 |
| Stage1-vs-Stage2 |
6.313900E-02 |
| Stage1-vs-Stage3 |
1.132400E-01 |
| Stage1-vs-Stage4 |
1.57364999999743E-05 |
| Stage2-vs-Stage3 |
6.318600E-03 |
| Stage2-vs-Stage4 |
2.10840000000045E-05 |
| Stage3-vs-Stage4 |
8.421400E-03 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.45439216225896E-13 |
| Normal-vs-AfricanAmerican |
1.64565999999366E-05 |
| Normal-vs-Asian |
2.8079000014003E-08 |
| Caucasian-vs-AfricanAmerican |
8.944400E-01 |
| Caucasian-vs-Asian |
4.947600E-01 |
| AfricanAmerican-vs-Asian |
7.481800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.47429965405388E-10 |
| Normal-vs-Female |
5.25549603835884E-11 |
| Male-vs-Female |
6.487400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.70163882984298E-12 |
| Normal-vs-Age(41-60Yrs) |
6.24910123647737E-11 |
| Normal-vs-Age(61-80Yrs) |
6.16759998628424E-09 |
| Normal-vs-Age(81-100Yrs) |
4.184500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.583400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.083400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.176800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.851800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.768400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.180200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.995500E-04 |
| Classical-VS-Follicular |
7.49230000041123E-07 |
| Classical-VS-Other |
1.754000E-01 |
| Classical-VS-Normal |
1.64335212105016E-12 |
| Tall-VS-Follicular |
1.65410019015155E-10 |
| Tall-VS-Other |
5.820100E-02 |
| Tall-VS-Normal |
9.99200722162641E-16 |
| Follicular-VS-Other |
6.246000E-01 |
| Follicular-VS-Normal |
1.588140E-02 |
| Other-VS-Normal |
6.975900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.1889000006704E-08 |
| Normal-vs-N1 |
2.1049828546893E-13 |
| N0-vs-N1 |
7.610200E-04 |
|
|
